KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Feb 12, 2016 $21.33 $21.33 $21.33 $21.33 1 180 000
Feb 11, 2016 $20.32 $20.32 $20.32 $20.32 835 400
Feb 10, 2016 $20.45 $20.45 $20.45 $20.45 425 200
Feb 09, 2016 $20.47 $20.47 $20.47 $20.47 620 300
Feb 08, 2016 $20.05 $20.05 $20.05 $20.05 842 700
Feb 05, 2016 $22.14 $22.14 $22.14 $22.14 796 400
Feb 04, 2016 $24.09 $24.09 $24.09 $24.09 537 100
Feb 03, 2016 $24.11 $24.11 $24.11 $24.11 873 100
Feb 02, 2016 $25.12 $25.12 $25.12 $25.12 767 500
Feb 01, 2016 $25.39 $25.39 $25.39 $25.39 1 021 400
Jan 29, 2016 $24.18 $24.18 $24.18 $24.18 1 193 700
Jan 28, 2016 $25.47 $25.47 $25.47 $25.47 765 000
Jan 27, 2016 $26.39 $26.39 $26.39 $26.39 481 300
Jan 26, 2016 $27.76 $27.76 $27.76 $27.76 439 100
Jan 25, 2016 $29.03 $29.03 $29.03 $29.03 475 200
Jan 22, 2016 $29.37 $29.37 $29.37 $29.37 579 800
Jan 21, 2016 $29.00 $29.00 $29.00 $29.00 604 200
Jan 20, 2016 $29.39 $29.39 $29.39 $29.39 760 000
Jan 19, 2016 $28.05 $28.05 $28.05 $28.05 1 167 200
Jan 15, 2016 $29.13 $29.13 $29.13 $29.13 1 055 700
Jan 14, 2016 $28.97 $28.97 $28.97 $28.97 1 258 700
Jan 13, 2016 $26.05 $26.05 $26.05 $26.05 839 600
Jan 12, 2016 $28.75 $28.75 $28.75 $28.75 909 800
Jan 11, 2016 $27.30 $27.30 $27.30 $27.30 766 700
Jan 08, 2016 $30.26 $30.26 $30.26 $30.26 722 800
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT